Albutein

Albutein Manufacturers

• Grifols Usa, Llc
  

  ×

  Albutein | Grifols Usa, Llc

  

  ---

  For Intravenous Use Only

  2.1 Dosage

  Adjust the concentration, dosage and infusion rate of the albumin preparation to the patient's individual requirements.

  The dose required depends on the patient's body weight, severity of injury/illness and on continuing fluid and protein losses. Use adequacy of circulating blood volume, not plasma albumin levels, to determine the dose required.

  Indication Dose Hypovolemia Adults: Initial dose of 25 g.
  If hemodynamic stability is not achieved within 15 to 30 minutes, an additional dose may be given.
  Hemodilution may follow administration of Albutein 25%. Anemia resulting from hemorrhage should be corrected by administration of compatible red blood cells or compatible whole blood.
  For acute liver failure: initial dose of 12 to 25 g. An infusion rate of 1-2 mL per minute is usually indicated.
  For renal dialysis, the initial dose should not exceed 25 g and patients should be carefully observed for signs of fluid overload. Cardiopulmonary bypass procedures Adults: Initial dose of 25 g. Additional amounts may be administered as clinically indicated. Acute nephrosis Adults: 25 g together with diuretic once a day for 7 - 10 days. Hypoalbuminemia Adults: 50 to 75 g
  For pre- and post-operative hypoproteinemia: 50 to 75 g.
  In burns, therapy usually starts with administration of large volumes of crystalloid solution to maintain plasma volume. After 24 hours: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL or a serum protein concentration of 5.2 g per 100 mL.
  Third space protein loss due to infection: initial dose of 50 to 100 g. An infusion rate of 1-2 mL per minute is usually indicated in the absence of shock. Treatment should always be guided by hemodynamic response. Ovarian hyperstimulation syndrome Adults: 50 g to 100 g over 4 hours and repeated at 4-12 hour intervals as necessary, when infusion of normal saline fails to achieve or maintain hemodynamic stability and urine output. Neonatal hyperbilirubinemia 1 g per kilogram body weight prior to or during exchange transfusion. Adult respiratory distress syndrome (ARDS) Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if necessary. Prevention of central volume depletion after paracentesis due to cirrhotic ascites Adults: 8 g for every 1000 mL of ascitic fluid removed. 2.2 Administration

  Intravenous use only

  Albutein 25% is a clear and slightly viscous solution. Visually inspect parenteral drug products for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if the solution is turbid or if there is sediment in the bottle. Do not freeze. Warm product to room temperature before use if large volumes are administered. Albutein 25% contains no preservatives. Do not begin administration more than 4 hours after the container has been entered. Discard unused portion. Do not dilute with sterile water for injection. The product can be diluted in an isotonic solution. (e.g., 5% Dextrose in Water or 0.9% sodium chloride) [see Warnings and Precautions (5.7)]. Adjust the infusion rate to the individual circumstances and the indication.

  Close
  No Recall

  More Info
• Grifols Usa, Llc
  

  ×

  Albutein | Grifols Usa, Llc

  

  ---

  For Intravenous Use Only

  2.1 Dosage

  Adjust the concentration, dosage and infusion rate of the albumin preparation to the patient's individual requirements.

  The dose required depends on the patient's body weight, severity of injury/illness and on continuing fluid and protein losses. Use adequacy of circulating blood volume, not plasma albumin levels, to determine the dose required.

  Indication Dose Hypovolemia Adults: Initial dose of 20 g.
  If hemodynamic stability is not achieved within 15 to 30 minutes, an additional dose may be given.
  Hemodilution may follow administration of Albutein 20%. Anemia resulting from hemorrhage should be corrected by administration of compatible red blood cells or compatible whole blood.
  For acute liver failure: initial dose of 12 to 25 g. An infusion rate of 1-2 mL per minute is usually indicated.
  For renal dialysis, the initial dose should not exceed 20 g and patients should be carefully observed for signs of fluid overload. Cardiopulmonary bypass procedures Adults: Initial dose of 25 g. Additional amounts may be administered as clinically indicated. Acute nephrosis Adults: 25 g together with diuretic once a day for 7 - 10 days. Hypoalbuminemia Adults: 50 to 75 g
  For pre- and post-operative hypoproteinemia: 50 to 75 g.
  In burns, therapy usually starts with administration of large volumes of crystalloid solution to maintain plasma volume. After 24 hours: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL or a serum protein concentration of 5.2 g per 100 mL.
  Third space protein loss due to infection: initial dose of 50 to 100 g. An infusion rate of 1-2 mL per minute is usually indicated in the absence of shock. Treatment should always be guided by hemodynamic response. Ovarian hyperstimulation syndrome Adults: 50 g to 100 g over 4 hours and repeated at 4-12 hour intervals as necessary, when infusion of normal saline fails to achieve or maintain hemodynamic stability and urine output. Neonatal hyperbilirubinemia 1 g per kilogram body weight prior to or during exchange transfusion. Adult respiratory distress syndrome (ARDS) Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if necessary. Prevention of central volume depletion after paracentesis due to cirrhotic ascites Adults: 8 g for every 1000 mL of ascitic fluid removed. 2.2 Administration

  Intravenous use only

  Albutein 20% is a clear and slightly viscous solution. Visually inspect parenteral drug products for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if the solution is turbid or if there is sediment in the bottle. Do not freeze. Warm product to room temperature before use if large volumes are administered. Albutein 20% contains no preservatives. Do not begin administration more than 4 hours after the container has been entered. Discard unused portion. Do not dilute with sterile water for injection. The product can be diluted in an isotonic solution (e.g., 5% Dextrose in Water or 0.9% sodium chloride) [see Warnings and Precautions (5.7)]. Adjust the infusion rate to the individual circumstances and the indication.

  Close
  No Recall

  More Info
• Grifols Usa, Llc
  

  ×

  Albutein | Grifols Usa, Llc

  

  ---

  For Intravenous Use Only

  2.1 Dosage

  Adjust the concentration, dosage and infusion rate of the albumin preparation to the patient's individual requirements.

  The dose required depends on the patient's body weight, severity of injury/illness and on continuing fluid and protein losses. Use adequacy of circulating blood volume, not plasma albumin levels, to determine the dose required.

  Indication Dose Hypovolemia Adults: Initial dose of 20 g.
  If hemodynamic stability is not achieved within 15 to 30 minutes, an additional dose may be given.
  Hemodilution may follow administration of Albutein 5%. Anemia resulting from hemorrhage should be corrected by administration of compatible red blood cells or compatible whole blood.
  For acute liver failure: initial dose of 12 to 25 g. An infusion rate of 1-2 mL per minute is usually indicated.
  For renal dialysis, the initial dose should not exceed 20 g and patients should be carefully observed for signs of fluid overload. Cardiopulmonary bypass procedures Adults: Initial dose of 25 g. Additional amounts may be administered as clinically indicated. Hypoalbuminemia Adults: 50 to 75 g
  For pre- and post-operative hypoproteinemia: 50 to 75 g.
  In burns, therapy usually starts with administration of large volumes of crystalloid solution to maintain plasma volume. After 24 hours: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL or a serum protein concentration of 5.2 g per 100 mL.
  Third space protein loss due to infection: initial dose of 50 to 100 g. An infusion rate of 1-2 mL per minute is usually indicated in the absence of shock. Treatment should always be guided by hemodynamic response. Plasma exchange The dosage and infusion rate of Albutein 5% infused should be titrated to the volume of plasma removed during the procedure. 2.2 Administration

  Intravenous use only

  Albutein 5% is a clear and slightly viscous solution. Visually inspect parenteral drug products for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if the solution is turbid or if there is sediment in the bottle. Do not freeze. Warm product to room temperature before use if large volumes are administered. Albutein 5% contains no preservatives. Do not begin administration more than 4 hours after the container has been entered. Discard unused portion. Do not dilute with sterile water for injection [see Warnings and Precautions (5.6)]. Adjust the infusion rate to the individual circumstances and the indication. In plasma exchange, adjust the infusion rate to the rate of plasma removal.

  Close
  No Recall

  More Info